Search

ENANTA PHARMACEUTICALS INC

Atidarymo kaina

SektoriusSveikatos priežiūra

13.99 -0.07

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

13.57

Max

14.65

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-6.4M

-20M

Pardavimai

-2.8M

14M

Pelnas, tenkantis vienai akcijai

-0.67

Pelno marža

-135.81

Darbuotojai

120

EBITDA

-6.8M

-15M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+41.84% upside

Dividendai

By Acuity

Kitas uždarbis

2026-11-13

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-27M

374M

Ankstesnė atidarymo kaina

14.06

Ankstesnė uždarymo kaina

13.99

Naujienos nuotaikos

By Acuity

71%

29%

311 / 340 reitingas Healthcare

ENANTA PHARMACEUTICALS INC Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-24 19:06; UTC

News

Enanta Pharmaceuticals is rising despite recent downgrades, remaining above its 20-day moving average. HC Wainwright maintains a "buy" rating with a $20 target.

2026-08-21 19:41; UTC

Enanta Pharmaceuticals is trading higher, supported by gains in biotechnology stocks. The asset remains above its 20-day moving average during Friday's session.

2026-08-20 19:31; UTC

Enanta Pharmaceuticals Inc. shares are lower today amid pressure on biotechnology stocks, continuing a decline since Wednesday's close. No specific news was identified.

2026-08-18 19:16; UTC

Enanta Pharmaceuticals is trading higher today, supported by a rally in the Biotechnology sub-sector. Shares have gained since Monday's close.

2026-08-17 20:06; UTC

Enanta Pharmaceuticals Inc shares are lower today, continuing a decline since Friday amid broader market weakness following a drop in U.S. retail sales.

2026-08-14 20:06; UTC

Enanta Pharmaceuticals is trading lower amid mixed market sentiment following a reported decline in U.S. retail sales for July.

2026-08-13 19:36; UTC

Enanta Pharmaceuticals Inc is trading higher, remaining above its 20-day moving average, despite no specific company news identified for the price movement.

2026-08-11 20:06; UTC

Enanta Pharmaceuticals Inc shares are lower today, reflecting broader market declines. The stock reached a session low earlier but has since recovered slightly.

2026-08-05 19:46; UTC

Enanta Pharmaceuticals Inc shares are lower, reflecting broader market sentiment amid disappointing ADP employment data showing a rise of only 44,000 jobs in July.

2026-08-04 19:46; UTC

Enanta Pharmaceuticals Inc shares are higher, buoyed by a decline in crude oil prices that eases inflation concerns. No specific company news was identified.

2026-08-03 19:23; UTC

Enanta Pharmaceuticals Inc shares are rising amid a broader market rally, supported by gains in major technology stocks and renewed investor confidence.

2026-07-31 20:06; UTC

Enanta Pharmaceuticals Inc's shares are lower today, continuing a downward trend amid rising U.S. Treasury yields and crude oil prices. No specific news was identified.

2026-07-30 19:45; UTC

Enanta Pharmaceuticals Inc. is advancing, supported by broader market gains. Earlier in the session, shares pulled back from a session high.

2026-07-29 18:26; UTC

Enanta Pharmaceuticals Inc is declining in Wednesday's session, marking the seventh consecutive day of lower prices. No specific news has been identified to explain the movement.

2026-07-28 20:06; UTC

Enanta Pharmaceuticals Inc is declining, marking five consecutive sessions lower. The stock peaked earlier but has since pulled back amid broader market pressures.

2026-07-27 18:36; UTC

Enanta Pharmaceuticals Inc is higher today, building on Friday's momentum amid broader market dynamics following a decline in oil prices.

2026-07-24 20:06; UTC

Enanta Pharmaceuticals Inc. shares are lower today, reversing from a recent trend of higher daily closes since Thursday's close.

2026-07-21 19:31; UTC

Enanta Pharmaceuticals is rising during Tuesday's session, reflecting broader market strength and positive sentiment from recent earnings reports by General Motors and Novartis.

2026-07-20 19:46; UTC

Enanta Pharmaceuticals Inc shares are lower today, continuing a decline since Friday's close. The stock has shown significant volatility during the session.

Akcijų palyginimas

Kainos pokytis

ENANTA PHARMACEUTICALS INC Prognozė

Kainos tikslas

By TipRanks

41.84% į viršų

12 mėnesių prognozė

Vidutinis 20 USD  41.84%

Aukščiausias 20 USD

Žemiausias 20 USD

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines ENANTA PHARMACEUTICALS INC kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

1 ratings

1

Pirkti

0

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

311 / 340 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Meškų rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę ENANTA PHARMACEUTICALS INC

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. The company has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. Enanta Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Watertown, Massachusetts.
help-icon Live chat